Longitudinal Monitoring of Progressive Supranuclear Palsy using Body‐Worn Movement Sensors. Issue 11 (31st August 2022)

• Record Type: Journal Article
• Authors: Sotirakis, Charalampos; Conway, Niall; Su, Zi; Villarroel, Mauricio; Tarassenko, Lionel; FitzGerald, James J.; Antoniades, Chrystalina A.
• Is Part Of: Movement disorders. Volume 37:Issue 11(2022)
• Page Start: 2263
• Page End: 2271
• Publication Date: 2022-08-31
• Subjects: clinical rating scales -- gait and posture -- inertial measurement units -- kinematic features -- machine learning -- wearable sensors; Movement disorders -- Periodicals; 610
• DOI: 10.1002/mds.29194
• Languages: English
• ISSNs: 0885-3185

Abstract

Abstract: Background: We have previously shown that wearable technology and machine learning techniques can accurately discriminate between progressive supranuclear palsy (PSP), Parkinson's disease, and healthy controls. To date these techniques have not been applied in longitudinal studies of disease progression in PSP. Objectives: We aimed to establish whether data collected by a body‐worn inertial measurement unit (IMU) network could predict clinical rating scale scores in PSP and whether it could be used to track disease progression. Methods: We studied gait and postural stability in 17 participants with PSP over five visits at 3‐month intervals. Participants performed a 2‐minute walk and an assessment of postural stability by standing for 30 seconds with their eyes closed, while wearing an array of six IMUs. Results: Thirty‐two gait and posture features were identified, which progressed significantly with time. A simple linear regression model incorporating the three features with the clearest progression pattern was able to detect statistically significant progression 3 months in advance of the clinical scores. A more complex linear regression and a random forest approach did not improve on this. Conclusions: The reduced variability of the models, in comparison to clinical rating scales, allows a significant change in disease status from baseline to be observed at an earlier stage. The current study sheds light on the individual features that are important in tracking disease progression. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society